S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden’s $374B Giveaway Into This Sector (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden’s $374B Giveaway Into This Sector (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden’s $374B Giveaway Into This Sector (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden’s $374B Giveaway Into This Sector (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
TSE:BLU

BELLUS Health (BLU) Stock Price, News & Analysis

→ The Next Nvidia? (From InvestorPlace) (Ad)
Free BLU Stock Alerts
Compare
Today's Range
N/A
50-Day Range
C$19.48
▼
C$19.48
52-Week Range
N/A
Volume
28,666 shs
Average Volume
59,471 shs
Market Capitalization
C$2.47 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider Trades
BLU stock logo

About BELLUS Health Stock (TSE:BLU)

BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.

BLU Stock News Headlines

April 16, 2024 | americanbankingnews.com
BELLUS Health (TSE:BLU) Stock Passes Above Fifty Day Moving Average of $19.48
April 1, 2024 | msn.com
Legacy Health reaches Regence Blue Cross deal
April 18, 2024 | InvestorPlace (Ad)
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
February 7, 2024 | msn.com
Is Blue Cross Blue Shield your health plan? Dignity Health providers are no longer in your network
February 6, 2024 | msn.com
Blue Cross Blue Shield no longer has a contract with Dignity Health. Here's what we know
February 3, 2024 | morningstar.com
Mind Medicine Inc Ordinary Shares MNMD
December 22, 2023 | sfgate.com
Adventist Health Hospitals To Once Again Accept Blue Shield Of California Patients
December 5, 2023 | msn.com
Algernon Pharmaceuticals: Investigating a Novel Therapy for Stroke Patients Using the Psychedelic Drug N,N-Dimethyltryptamine (DMT)
April 18, 2024 | InvestorPlace (Ad)
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
October 30, 2023 | benzinga.com
Bellus Beauty: The New England Beauty Brand Revolutionizing Skincare
August 10, 2023 | finance.yahoo.com
COMMODORE CAPITAL LP Acquires New Stake in Vistagen Therapeutics Inc
April 27, 2023 | theglobeandmail.com
Closing Bell: Bellus Health Inc down on Thursday (BLU)
April 24, 2023 | theglobeandmail.com
Closing Bell: Bellus Health Inc down on Monday (BLU)
April 21, 2023 | theglobeandmail.com
Closing Bell: Bellus Health Inc up on Friday (BLU)
April 20, 2023 | benzinga.com
BELLUS Health Stock (NASDAQ:BLU), Short Interest Report
April 18, 2023 | markets.businessinsider.com
Canadian Market Modestly Higher; Bellus Health Soars On Acquisition News
April 18, 2023 | benzinga.com
Moore Kuehn Encourages RXDX, STSA, CHRA, and BLU Investors to Contact Law Firm
April 18, 2023 | finance.yahoo.com
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
April 18, 2023 | theglobeandmail.com
GSK plans to buy Canada-based drug developer Bellus Health for $2-billion
April 18, 2023 | proactiveinvestors.com
GSK pays £1.6bn for Canada's Bellus Health
April 18, 2023 | msn.com
GSK bets $2 billion on Bellus cough drug to soothe pipeline fears
April 18, 2023 | msn.com
Bellus surges ~100% after GSK reaches deal to acquire cough drugmaker for ~$2B
April 18, 2023 | msn.com
GSK to Acquire Bellus Health for $2 Billion
April 18, 2023 | msn.com
GSK to acquire Canada’s Bellus Health for $14.75 per share
April 6, 2023 | theglobeandmail.com
Closing Bell: Bellus Health Inc down on Wednesday (BLU)
March 6, 2023 | msn.com
4 Biotech Stocks That Could Break Through the Market
March 1, 2023 | finance.yahoo.com
BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference
See More Headlines
Receive BLU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:BLU
CUSIP
N/A
CIK
N/A
Web
www.bellushealth.com
Phone
+1-450-6804500
Fax
N/A
Employees
74
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.96)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-86,790,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-26.76%
Return on Assets
-16.70%

Debt

Debt-to-Equity Ratio
0.32
Current Ratio
33.42
Quick Ratio
16.40

Sales & Book Value

Annual Sales
C$16,000.00
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
4.67
Book Value
C$2.91 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
126,810,000
Free Float
N/A
Market Cap
C$2.47 billion
Optionable
Not Optionable
Beta
-0.28
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Roberto Francesco Bellini (Age 43)
    Pres, CEO & Director
    Comp: $790.35k
  • Mr. Ramzi Benamar (Age 50)
    Chief Financial Officer
    Comp: $650.48k
  • Dr. Andreas Orfanos FFPM (Age 64)
    M.B.B.Ch, MBA, Chief Operating Officer
    Comp: $417.58k
  • Dr. Denis Garceau Ph.D. (Age 66)
    Chief Scientific Officer
    Comp: $496.56k
  • Dr. Catherine M. Bonuccelli M.D. (Age 65)
    Chief Medical Officer
    Comp: $741.66k
  • Mr. Daniel Matthews
    Director of Investor Relations & Communications
  • Mr. Tony Matzouranis (Age 50)
    Chief Bus. Officer
  • Mr. Sebastien Roy (Age 47)
    Corp. Sec.

Key Competitors

View All Competitors

BLU Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of BELLUS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BELLUS Health investors own include Exxon Mobil (XOM), Bombardier (BDRBF), AbbVie (ABBV), Energy Transfer (ET), General Electric (GE), Coca-Cola (KO), Alexion Pharmaceuticals (ALXN), Advanced Micro Devices (AMD), Boeing (BA) and Walt Disney (DIS).

How do I buy shares of BELLUS Health?

Shares of BLU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:BLU) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
The “Perfect Storm” for Gold
Gold Safe Exchange
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The Next Nvidia?
InvestorPlace